| |
| |
|
| Insider
Information: |
Mily Elizabeth |
| Relationship: |
EVP, Strategy & BD |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
30,396 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,363,261 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,396 |
|
|
| Total
Value |
$1,363,261 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, Strategy & BD |
2023-03-10 |
30,396 |
2021-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2023-03-10 |
4 |
D |
$65.71 |
$922,568 |
D/D |
(14,040) |
30,396 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2023-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,458 |
40,856 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,636 |
38,173 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2022-04-01 |
4 |
D |
$73.82 |
$246,042 |
D/D |
(3,333) |
11,342 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2022-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,347 |
12,481 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,508 |
11,990 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2022-03-10 |
4 |
D |
$68.42 |
$128,288 |
D/D |
(1,875) |
6,820 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
449 |
8,695 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,005 |
8,246 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2021-04-01 |
4 |
D |
$62.93 |
$185,769 |
D/D |
(2,952) |
4,241 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2021-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,346 |
5,380 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Strategy & BD |
• – – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
847 |
4,509 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
